Cellgram-ED (autologous mesenchymal stem cell therapy)
/ Pharmicell
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
February 10, 2026
Cellgram-ED: Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously
(clinicaltrials.gov)
- P2 | N=54 | Completed | Sponsor: Pharmicell Co., Ltd. | Recruiting ➔ Completed
Trial completion • Erectile Dysfunction
April 12, 2024
Cellgram-ED: Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously
(clinicaltrials.gov)
- P2 | N=54 | Recruiting | Sponsor: Pharmicell Co., Ltd. | Trial completion date: Oct 2023 ➔ Jan 2026 | Trial primary completion date: Oct 2023 ➔ Dec 2025
Trial completion date • Trial primary completion date • Erectile Dysfunction
October 20, 2020
Cellgram-ED: Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously
(clinicaltrials.gov)
- P2; N=54; Recruiting; Sponsor: Pharmicell Co., Ltd.
Clinical • New P2 trial • Erectile Dysfunction
1 to 3
Of
3
Go to page
1